In observance of Thanksgiving, Genway Biotech office will be closed on Thursday and Friday, November 22-23, 2018

RC-160 (Vapreotide)



Add to Cart


Sequence (One Letter Code): FCYWKVCW-NH

Sequence: {d-PHE} {CYS} {TYR} {d-TRP} {LYS} {VAL} {CYS} {TRP}-NH2 C Terminal: NH2

Formula: C57H70N12O9S2 Chemical Bridge: Disulfide bridge: Cys2-Cys7

Solubility: Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents. RC-160 (octastatin/vapreotide) is a potent octapeptide analogue of somatostatin with growth inhibitory activity in experimental tumours in vitro and in vivo. including breast cancer. high-dose RC-160. can reduce serum levels of the breast growth factors IGF-I and prolactin but is ineffective in the management of metastatic breast cancer. Encouraging preclinical anti-tumour activity and the favourable toxicity profile in patients suggest the merit of future studies combining RC-160 with anti-oestrogen. cytotoxic and anti-angiogenic agents.


Additional Information

Name RC-160 (Vapreotide)
Related Product Names RC-160 (Vapreotide)
Swissprot ID Q8KW30
Molecular Weight 35825
Purity > 95%
Stability 6-12 months at -20 degree C.
Storage 4 degree C for short term (weeks) and -20 degree C for long term.
Datasheets/Manuals Printable datasheet for GWB-133358
Intended Use Research Use Only